Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3229 Target Snapshot

Fatty-acid amide hydrolase 1 · SINGLE PROTEIN · Rattus norvegicus

2,806Compounds
374Assays
5Approved Drugs
3,090.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P97612. Use UniProt P97612 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P97612 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Fatty-acid amide hydrolase 1 as ChEMBL target CHEMBL3229, mapped to UniProt P97612. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Fatty-acid amide hydrolase 1
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3229
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P97612
Fatty-acid amide hydrolase 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Fatty-acid amide hydrolase 1 is the right protein anchor across sources, using UniProt P97612 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelFatty-acid amide hydrolase 1
UniProt AccessionP97612
Component TypeProtein
Sequence Length579 aa

Fatty-acid amide hydrolase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Fatty-acid amide hydrolase 1, mapped to UniProt P97612. Sequence length is 579 aa.

Mapped IDP97612
Review nameFatty-acid amide hydrolase 1
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

5
Approved
1
Phase III
2
Phase II
3
Phase I
Assay Mix

Activity Type Distribution

IC502,288.0
KI796.0
EC505.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL367966 10.55 Ki 0.028 Preclinical
CHEMBL477372 10.3 Ki 0.05 Preclinical
CHEMBL3318616 10.0 Ki 0.1 Preclinical
CHEMBL4070196 10.0 IC50 0.1 Preclinical
CHEMBL175580 9.85 Ki 0.14 Preclinical
CHEMBL3318605 9.8 Ki 0.16 Preclinical
CHEMBL3318613 9.8 Ki 0.16 Preclinical
CHEMBL3113272 9.77 IC50 0.17 Preclinical
CHEMBL3318617 9.72 Ki 0.19 Preclinical
CHEMBL175854 9.7 Ki 0.2 Preclinical
Distribution

pChEMBL Value Distribution

227
5.0
218
5.5
250
6.0
286
6.5
379
7.0
380
7.5
313
8.0
174
8.5
104
9.0
34
9.5
pChEMBL
Approved Drugs

Approved Drugs

ORLISTAT
CHEMBL175247
Approved 1998
Assay Landscape

Assay Landscape

374
Total Assays
2,176
Tested Compounds
3
Assay Types
Binding — 342 assays, 2,176 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 126 855 7.2
tissue-based format 68 297 6.4
single protein format 66 541 6.9
cell membrane format 40 229 6.5
cell-based format 26 99 7.4
microsome format 11 154 7.0
subcellular format 5 1 7.0
Functional — 28 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 24 0
assay format 2 0
cell membrane format 2 0
ADME — 4 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 2 0
tissue-based format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine